Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Novus Therapeutics begins phase 1 trial of OP0201 in otitis media Novus Therapeutics has launched a phase 1 pharmacodynamics clinical trial for its promising candidate, OP0201, aimed at treating… bypharmanewsdailyFebruary 11, 2019